President Donald Trump said reductions in prescription drug prices will play a major role in the upcoming midterm elections, calling the cuts a “shock to the system” that will benefit millions of Americans. Trump announced that Pfizer will allow state Medicaid programs to access medications at most-favored-nation (MFN) prices — the lowest costs available among developed nations. According to a White House fact sheet, several drugs will see dramatic reductions. Eucrisa, a treatment for dermatitis, will be offered at an 80 percent discount. Xeljanz, a rheumatoid arthritis drug, will be reduced by 40 percent, while Zavzpret, used to treat migraines,...
Continues…